The FINANCIAL -- Abbott on January 12 is announcing its full-year earnings-per-share guidance for 2009 and confirming its previously issued 2008 earnings-per-share...

Abbott Expands Its Growing Medical Device Business with Acquisition of Advanced Medical Optics

by The FINANCIAL

January 12, 2009

The FINANCIAL -- Abbott and Advanced Medical Optics (AMO) (NYSE: EYE) announced on January 12 a definitive agreement for Abbott to acquire...

Novartis strengthens vaccine pipeline with agreement for novel CMV vaccines candidate

by The FINANCIAL

December 29, 2008

The FINANCIAL -- Novartis has strengthened its vaccines pipeline through an exclusive agreement to license AlphaVax' investigational Cytomegalovirus (CMV) vaccine...

Johnson & Johnson Completes Tender Offer For Omrix Biopharmaceuticals, Inc.

by The FINANCIAL

December 29, 2008

The FINANCIAL -- Johnson & Johnson (NYSE: JNJ) on December 27 announced that stockholders of Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI) (“Omrix”) tendered approximately...

Takeda Starts Phase 3 Clinical Studies of ATL-962 a Treatment for Obesity and Related Diseases

by The FINANCIAL

December 22, 2008

The FINANCIAL -- Takeda Pharmaceutical Company Limited (“Takeda”) on December 22 announced that it has started a phase 3 clinical study of...

Approval of an Additional Indication of ACTOS in Japan

by The FINANCIAL

December 22, 2008

The FINANCIAL -- Takeda Pharmaceutical Company Limited (“Takeda”) announced on December 22 that an additional indication of concomitant therapy with biguanides...

Sanofi-aventis and Novozymes announce a development and commercialization collaboration

by The FINANCIAL

December 22, 2008

The FINANCIAL -- Sanofi-aventis announced on December 22 the signature of a global licensing and collaboration agreement with Novozymes for the development...

FDA Approves LUSEDRA Injection for Monitored Anesthesia Care (MAC) Sedation

by The FINANCIAL

December 15, 2008

The FINANCIAL -- Eisai Corporation of North America on December 14 announced that the U.S. Food and Drug Administration (FDA) has approved...

Sanofi-aventis was granted the 2008 China Charity Award

by The FINANCIAL

December 15, 2008

The FINANCIAL -- Sanofi-aventis announced on December 15 that it was granted the “2008 China Charity Award” by the Ministry of Civil...

DOXIL Combination Therapy Delays Disease Progression for Patients with Metastatic Breast Cancer

by The FINANCIAL

December 15, 2008

The FINANCIAL -- Results from a Phase 3 study show that patients with metastatic breast cancer who were treated previously...

Results of Two Large Phase III Trials (CLL8 and REACH)

by The FINANCIAL

December 8, 2008

The FINANCIAL -- Genentech, Inc. (NYSE: DNA) and Biogen Idec (Nasdaq: BIIB) on December 6 announced that two global Phase III studies...

DAIICHI SANKYO Initiates Phase III Trial of its Investigational Factor Xa Inhibitor, DU-176b

by The FINANCIAL

December 8, 2008

The FINANCIAL -- Patients with non-valvular atrial fibrillation receiving either 30 mg or 60 mg once-daily dose of DU-176b, an...

Jonathan Knowles to retire from Roche at the end of 2009

by The FINANCIAL

December 8, 2008

The FINANCIAL -- Prof. Jonathan Knowles, Head of Group Research and member of the Corporate Executive Committee of Roche, will...

Merck Reaffirms Cardiovascular Research Commitment

by The FINANCIAL

December 8, 2008

The FINANCIAL -- Merck & Co., Inc. on December 8 reaffirmed its commitment to discovering and developing novel treatments for a broad...

GlaxoSmithKline Says Promacta Elevates Platelet Count In Chronic ITP Patients

by The FINANCIAL

December 8, 2008

The FINANCIAL -- GlaxoSmithKline (GSK) on December 6 presented positive safety and efficacy results from RAISE (RAndomised placebo-controlled ITP Study with Eltrombopag),...